Advertisement

Topics

AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease burden in leukaemia patients

15:02 EDT 3 Apr 2017 | ecancermedicalscience

Although most patients with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced complete response after treatment with a type of CAR T-cell immunotherapy, pretreatment disease burden impacted the durability of the responses and longterm...

Original Article: AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease burden in leukaemia patients

NEXT ARTICLE

More From BioPortfolio on "AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease burden in leukaemia patients"

Quick Search
Advertisement